The impact of epidermal-growth-factor-receptor mutations in response to lung-cancer therapy

被引：0
|
作者：
Jonathan E Dowell
John D Minna
机构：
[1] University of Texas Southwestern Medical Center,Director of Hamon Center for Therapeutic Oncology Research and a Professor in the Departments of Internal Medicine and Pharmacology
[2] Chief of Hematology and Oncology at the Dallas Veterans Affairs Medical Center,undefined
来源：
Nature Clinical Practice Oncology | 2004年 / 1卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Non-small-cell lung cancer is the leading cause of cancer death in the US despite advances in therapy. The epidermal-growth-factor receptor has been investigated as a target for therapy using EGFR-specific tyrosine kinase inhibitors. This Viewpoint discusses the implications of the correlation of positive responses seen in patients harboringEGFRmutations.
引用
收藏
页码：2 / 3
页数：1
相关论文
共 50 条
  • [1] The impact of epidermal-growth-factor-receptor mutations in response to lung-cancer therapy
    Dowell, Jonathan E.
    Minna, John D.
    NATURE CLINICAL PRACTICE ONCOLOGY, 2004, 1 (01): : 2 - 3
  • [2] Epidermal growth factor receptor mutations in lung cancer
    Sharma, Sreenath V.
    Bell, Daphne W.
    Settleman, Jeffrey
    Haber, Daniel A.
    NATURE REVIEWS CANCER, 2007, 7 (03) : 169 - 181
  • [3] Epidermal growth factor receptor mutations in lung cancer
    Sreenath V. Sharma
    Daphne W. Bell
    Jeffrey Settleman
    Daniel A. Haber
    Nature Reviews Cancer, 2007, 7 : 169 - 181
  • [4] Epidermal growth factor receptor mutations and susceptibility to targeted therapy in lung cancer
    Ahmed, Syed M.
    Salgia, Ravi
    RESPIROLOGY, 2006, 11 (06) : 687 - 692
  • [5] Impact of smoking status and pathologic type on epidermal growth factor receptor mutations in lung cancer
    Huang Yi-sheng
    Yang Jin-ji
    Zhang Xu-chao
    Yang Xue-ning
    Huang Yu-juan
    Xu Chong-rui
    Zhou Qing
    Wang Zhen
    Su Jian
    Wu Yi-long
    CHINESE MEDICAL JOURNAL, 2011, 124 (16) : 2457 - 2460
  • [6] Impact of smoking status and pathologic type on epidermal growth factor receptor mutations in lung cancer
    HUANG Yi-sheng
    YANG Jin-ji
    ZHANG Xu-chao
    YANG Xue-ning
    HUANG Yu-juan
    XU Chong-rui
    ZHOU Qing
    WANG Zhen
    SU Jian
    WU Yi-long
    中华医学杂志（英文版）, 2011, (16) : 2457 - 2460
  • [7] Lung cancer epidermal growth factor receptor mutations and radiotherapy response: A multicentre clinical study
    Hsu, Fred
    Sit, Daegan
    Pastuch, Andrea
    Dingler, Angie
    Atwal, Parmveer
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2021, 30 : 15 - 18
  • [8] Epidermal Growth Factor Receptor Mutations in Small Cell Lung Cancer
    Tatematsu, Akiko
    Shimizu, Junichi
    Murakami, Yoshiko
    Horio, Yoshitsugu
    Nakamura, Shigeo
    Hida, Toyoaki
    Mitsudomi, Tetsuya
    Yatabe, Yasushi
    CLINICAL CANCER RESEARCH, 2008, 14 (19) : 6092 - 6096
  • [9] Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer.
    Rosell, Rafael
    Moran, Teresa
    Queralt, Cristina
    Porta, Rut
    Cardenal, Felipe
    Camps, Carlos
    Majem, Margarita
    Lopez-Vivanco, Guillermo
    Isla, Dolores
    Provencio, Mariano
    Insa, Amelia
    Massuti, Bartomeu
    Luis Gonzalez-Larriba, Jose
    Paz-Ares, Luis
    Bover, Isabel
    Garcia-Campelo, Rosario
    Angel Moreno, Miguel
    Catot, Silvia
    Rolfo, Christian
    Reguart, Noemi
    Palmero, Ramon
    Miguel Sanchez, Jose
    Bastus, Roman
    Mayo, Clara
    Bertran-Alamillo, Jordi
    Angel Molina, Miguel
    Javier Sanchez, Jose
    Taron, Miquel
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (10): : 958 - U38
  • [10] Epidermal growth factor receptor inhibitors in lung cancer therapy
    Laskin, JJ
    Sandier, AB
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 25 : 17 - 27
12345